Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,373 | 111 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $404.94 | 38 | $0 (2020) |
| Lilly USA, LLC | $368.01 | 29 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $193.45 | 14 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $86.11 | 6 | $0 (2021) |
| PFIZER INC. | $79.88 | 6 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $59.58 | 4 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $56.41 | 4 | $0 (2020) |
| Amgen Inc. | $36.58 | 3 | $0 (2018) |
| SANOFI PASTEUR INC. | $26.06 | 2 | $0 (2020) |
| GlaxoSmithKline, LLC. | $13.94 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $97.38 | 7 | PFIZER INC. ($28.68) |
| 2020 | $405.48 | 30 | Novo Nordisk Inc ($116.75) |
| 2019 | $250.57 | 19 | Lilly USA, LLC ($65.91) |
| 2018 | $173.83 | 14 | Lilly USA, LLC ($63.29) |
| 2017 | $445.91 | 41 | Novo Nordisk Inc ($198.80) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 01/27/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/20/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/03/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Diabetes | ||||||
| 11/19/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: RESPIRATORY | ||||||
| 11/17/2020 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Endocrinology | ||||||
| 11/11/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 10/22/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Diabetes | ||||||
| 10/08/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Obesity | ||||||
| 10/06/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Endocrinology | ||||||
| 09/24/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/23/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/02/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Endocrinology | ||||||
| 09/01/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: Diabetes | ||||||
| 08/26/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: RESPIRATORY | ||||||
| 07/28/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Endocrinology | ||||||
| 07/17/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 07/08/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 06/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 14 | 1,633 | 2,131 | $179,161 | $45,902 |
| 2020 | 33 | 3,535 | 6,009 | $496,951 | $151,714 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 290 | 394 | $96,530 | $23,514 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 210 | 296 | $45,880 | $12,469 | 27.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 184 | 186 | $6,510 | $2,491 | 38.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 133 | 146 | $7,738 | $1,418 | 18.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 347 | 461 | $4,149 | $1,373 | 33.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 15 | $4,545 | $1,046 | 23.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 28 | 93 | $3,534 | $990.64 | 28.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 22 | $2,046 | $554.84 | 27.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 86 | 88 | $2,200 | $405.48 | 18.4% |
| 85610 | Blood test, clotting time | Office | 2021 | 18 | 93 | $930.00 | $398.97 | 42.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 12 | 15 | $1,725 | $371.16 | 21.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 149 | 167 | $835.00 | $367.79 | 44.0% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 86 | 88 | $1,936 | $290.16 | 15.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 54 | 67 | $603.00 | $212.39 | 35.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 422 | 884 | $212,323 | $55,730 | 26.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 392 | 849 | $129,795 | $37,450 | 28.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 287 | 300 | $25,200 | $18,062 | 71.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 316 | 416 | $14,560 | $5,530 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 300 | 315 | $12,600 | $4,948 | 39.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 186 | 361 | $19,133 | $3,483 | 18.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 472 | 1,087 | $9,783 | $3,215 | 32.9% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 36 | 228 | $8,664 | $3,214 | 37.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 30 | 33 | $9,871 | $3,209 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $4,148 | $2,265 | 54.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 68 | 70 | $6,411 | $1,784 | 27.8% |
About Dr. Alan Crews, M.D
Dr. Alan Crews, M.D is a Specialist healthcare provider based in Dayton, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164497145.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Crews, M.D has received a total of $1,373 in payments from pharmaceutical and medical device companies, with $97.38 received in 2021. These payments were reported across 111 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,373).
As a Medicare-enrolled provider, Crews has provided services to 5,168 Medicare beneficiaries, totaling 8,140 services with total Medicare billing of $197,616. Data is available for 2 years (2020–2021), covering 47 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Dayton, TN
- Active Since 02/22/2006
- Last Updated 12/09/2009
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164497145
Products in Payments
- TRULICITY (Drug) $259.55
- FARXIGA (Drug) $193.45
- Ozempic (Drug) $143.80
- Victoza (Drug) $103.10
- Saxenda (Drug) $98.04
- BASAGLAR (Drug) $95.33
- JANUVIA (Drug) $56.41
- ELIQUIS (Drug) $54.27
- SOLIQUA 100/33 (Biological) $53.11
- CHANTIX (Drug) $39.49
- SPIRIVA RESPIMAT (Drug) $36.09
- Prolia (Biological) $26.01
- TOUJEO (Biological) $21.53
- Xultophy 100/3.6 (Drug) $17.22
- Tresiba (Drug) $15.46
- FLUZONE HIGH-DOSE (Biological) $14.12
- ANORO (Drug) $13.94
- HUMALOG (Drug) $13.13
- STIOLTO RESPIMAT (Drug) $12.34
- ADACEL (Drug) $11.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Dayton
Dr. Thomas Yunger, M.d, M.D
Specialist — Payments: $340,146
Dr. Rajesh Patel, M.d, M.D
Specialist — Payments: $67,937
Dr. Anuj Goyal, M.d, M.D
Specialist — Payments: $32,362
Dr. Ellen Pacia, M.d, M.D
Specialist — Payments: $14,571
Amit Goyal, Md, MD
Specialist — Payments: $7,646
Dr. Holly Hahn, M.d, M.D
Specialist — Payments: $3,711